You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 44 No. 11, November 1987 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (119)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Neuroendocrine Responses to Intravenous Tryptophan in Major Depression

Philip J. Cowen, MRCPsych; Eileen M. Charig, MB

Arch Gen Psychiatry. 1987;44(11):958-966.


Abstract



• The increases in plasma levels of prolactin (PRL) and growth hormone (GH) following intravenous administration of the 5-hydroxytryptamine precursor tryptophan (100 mg/kg) were assessed in 30 depressed patients and 30 control subjects. In depressed patients who lost less than 10 lb, PRL responses were significantly reduced compared with controls. In contrast, the PRL responses of patients with weight loss exceeding 10 lb were significantly greater than those of either controls or the other depressed patients. Growth hormone responses to tryptophan were significantly decreased in patients who lost less than 10 lb. Prolactin, but not GH, responses correlated significantly with the postdexamethasone plasma cortisol concentration; however, an apparent relationship between GH and PRL responses and suicidal behavior was probably due to the common factor of weight loss. The results suggest that depressed patients have different types of abnormal 5-hydroxytryptamine—mediated neuroendocrine responses that correlate with the presence or absence of severe weight loss and cortisol hypersecretion. Further investigations are needed to establish if these abnormalities are central to the depressive disorder or have implications for treatment response.



Author Affiliations



From the Medical Research Council Unit of Clinical Pharmacology and the University Department of Psychiatry, Research Unit, Littlemore Hospital, Oxford, England.


Footnotes



Accepted for publication June 7, 1987.

Reprint requests to University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford 0X4 4XN, England (Dr Cowen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neural and Behavioral Responses to Tryptophan Depletion in Unmedicated Patients With Remitted Major Depressive Disorder and Controls
Neumeister et al.
Arch Gen Psychiatry 2004;61:765-773.
ABSTRACT | FULL TEXT  

Association Between Serotonin Transporter Gene Promoter Polymorphism (5HTTLPR) and Behavioral Responses to Tryptophan Depletion in Healthy Women With and Without Family History of Depression
Neumeister et al.
Arch Gen Psychiatry 2002;59:613-620.
ABSTRACT | FULL TEXT  

Decreased sensitivity of 5-HT1D receptors in melancholic depression
WHALE et al.
Br. J. Psychiatry 2001;178:454-457.
ABSTRACT | FULL TEXT  

Molecular Abnormalities in Brains of Depressed Patients
Dowlatshahi and Young
Neuroscientist 2000;6:401-410.
ABSTRACT  

Impaired regulation of brain serotonin function during dieting in women recovered from depression
SMITH et al.
Br. J. Psychiatry 2000;176:72-75.
ABSTRACT | FULL TEXT  

Hormonal and Subjective Responses to Intravenous m-Chlorophenylpiperazine in Women With Seasonal Affective Disorder
Levitan et al.
Arch Gen Psychiatry 1998;55:244-249.
ABSTRACT | FULL TEXT  

Effects of Tryptophan Depletion in Drug-Free Depressed Patients Who Responded to Total Sleep Deprivation
Neumeister et al.
Arch Gen Psychiatry 1998;55:167-172.
ABSTRACT | FULL TEXT  

Hormonal and Subjective Responses to Intravenous meta-Chlorophenylpiperazine in Bulimia Nervosa
Levitan et al.
Arch Gen Psychiatry 1997;54:521-527.
ABSTRACT  

5 -HT, antidepressant drugs and the psychosocial origins of depression
Deakin
J Psychopharmacol 1996;10:31-38.
 

Serotonin and the Neurobiology of Depression: Effects of Tryptophan Depletion in Drug-Free Depressed Patients
Delgado et al.
Arch Gen Psychiatry 1994;51:865-874.
ABSTRACT  

Neuroendocrine Response to L-5-Hydroxytryptophan Challenge in Prepubertal Major Depression: Depressed vs Normal Children
Ryan et al.
Arch Gen Psychiatry 1992;49:843-851.
ABSTRACT  

Neuroendocrine Responses to m-Chlorophenylpiperazine and i-Tryptophan in Bulimia
Brewerton et al.
Arch Gen Psychiatry 1992;49:852-861.
ABSTRACT  

ECT treatment does not enhance neuroendocrine responses to serotonergic challenge
Manji et al.
J Psychopharmacol 1992;6:501-508.
ABSTRACT  

Serotonin Function and the Mechanism of Antidepressant Action: Reversal of Antidepressant-Induced Remission by Rapid Depletion of Plasma Tryptophan
Delgado et al.
Arch Gen Psychiatry 1990;47:411-418.
ABSTRACT  

Effects of Carbamazepine on Dopamine- and Serotonin-Mediated Neuroendocrine Responses
Elphick et al.
Arch Gen Psychiatry 1990;47:135-140.
ABSTRACT  

5-HT1A Receptors in major depression
Yates and Ferrier
J Psychopharmacol 1990;4:69-74.
ABSTRACT  

Effects of Desipramine and Fluvoxamine Treatment on the Prolactin Response to Tryptophan: Serotonergic Function and the Mechanism of Antidepressant Action
Price et al.
Arch Gen Psychiatry 1989;46:625-631.
ABSTRACT  

Lithium Treatment and Serotoninergic Function: Neuroendocrine and Behavioral Responses to Intravenous Tryptophan in Affective Disorder
Price et al.
Arch Gen Psychiatry 1989;46:13-19.
ABSTRACT  

Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication
Glue et al.
J Psychopharmacol 1988;2:119-137.
ABSTRACT  

The Effects of Dieting and Weight Loss on Neuroendocrine Responses to Tryptophan, Clonidine, and Apomorphine in Volunteers: Important Implications for Neuroendocrine Investigations in Depression
Goodwin et al.
Arch Gen Psychiatry 1987;44:952-957.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.